Abundant tumor promoting stromal cells in lung adenocarcinoma with hypoxic regions

Lung Cancer. 2018 Jan:115:56-63. doi: 10.1016/j.lungcan.2017.11.013. Epub 2017 Nov 20.

Abstract

Objectives: Carbonic anhydrase IX (CAIX) is a marker of hypoxia and its expression by cancer associated fibroblasts (CAFs) was reportedly associated with the poor prognosis of lung adenocarcinoma. This study aimed to characterize the hypoxic microenvironment containing CAIX (+) CAFs.

Materials and methods: First, we evaluated the clinicopathological significance of CAIX expression by CAFs in 3cm and above lung adenocarcinoma (n=188). We then compared the expressions of E-cadherin, ezrin, ALDH-1, CD44, EGFR, HSF-1, Glut-1, and PD-L1 in cancer cells, as well as those of CD204 and podoplanin in stromal cells between CAIX (+) CAFs and CAIX (-) CAFs cases (n=25, each).

Results: In total, 48 patients had CAIX (+) CAFs (26%). Multivariate analysis revealed that CAIX expression by CAFs could serve as an independent unfavorable prognostic factor for recurrence-free survival (p<0.05). The staining score of hypoxia marker Glut-1 in cancer cells was significantly higher in cases with CAIX (+) CAFs than in those with CAIX (-) CAFs (median: 20 vs. 0, p<0.01). In addition, the numbers of CD204 (+) tumor-associated macrophages (TAMs) and podoplanin (+) CAFs were significantly higher in the CAIX (+) CAFs group than in the CAIX (-) CAFs group (TAMs: 31.5 vs. 17.0: p<0.01, CAFs: 20 vs. 0: p<0.05). The staining score of the other markers did not differ between the groups.

Conclusion: Our results indicate that the presence of abundant tumor promoting stromal cells, CD204 (+) TAMs, and podoplanin (+) CAFs is characteristic of the tumor microenvironment containing CAIX (+) CAFs, which contributes to an increase in aggressive behavior in lung adenocarcinoma with hypoxic regions.

Keywords: Cancer associated fibroblasts; Carbonic anhydrase IX; Hypoxia; Microenvironment; Tumor-associated macrophages.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma of Lung / metabolism*
  • Adenocarcinoma of Lung / mortality
  • Adenocarcinoma of Lung / pathology
  • Aged
  • Biomarkers, Tumor / metabolism
  • Cancer-Associated Fibroblasts / physiology*
  • Carbonic Anhydrase IX / metabolism*
  • Glucose Transporter Type 1 / metabolism
  • Humans
  • Hypoxia
  • Lung Neoplasms / metabolism*
  • Lung Neoplasms / mortality
  • Lung Neoplasms / pathology
  • Male
  • Membrane Glycoproteins / metabolism
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Prognosis
  • Stromal Cells / physiology*
  • Survival Analysis
  • Tumor Microenvironment

Substances

  • Biomarkers, Tumor
  • Glucose Transporter Type 1
  • Membrane Glycoproteins
  • PDPN protein, human
  • Carbonic Anhydrase IX